Use of Lipid-modifying Therapy and LDL-C Goal Attainment in a High-Cardiovascular-Risk Population in the Netherlands-Reference-Cited by-同舟云学术

Use of Lipid-modifying Therapy and LDL-C Goal Attainment in a High-Cardiovascular-Risk Population in the Netherlands

Published:2017-04 Issue:4 Volume:39 Page:819-827.e1
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Kuiper Josephina G.,Sanchez Robert J.,Houben Eline,Heintjes Edith M.,Penning-van Beest Fernie J.A.,Khan Irfan,van Riemsdijk Melanie,Herings Ron M.C.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference33 articles.

1. European Heart Network and European Society of Cardiology. European Cardiovascular Disease Statistics. 2012. http://www.ehnheart.org/cvd-statistics.html.

2. Heart disease in the Netherlands: A quantitative update;Leening;Neth Heart J,2014

3. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins;Baigent;Lancet,2005

4. Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials;Baigent;Lancet,2010

5. Ezetimibe added to statin therapy after acute coronary syndromes;Cannon;N Engl J Med,2015

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of multicomponent crystal of piperine-nicotinic acid on antihyperlipidemic activity in rats;PAK J PHARM SCI;2023

2. Safety of bempedoic acid in patients at high cardiovascular risk and with statin intolerance;Journal of Clinical Lipidology;2023-10

3. Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention;American Journal of Cardiovascular Drugs;2023-07-24

4. Trends in low-density lipoprotein cholesterol goal achievement and changes in lipid-lowering therapy after incident atherosclerotic cardiovascular disease: Danish cohort study;PLOS ONE;2023-05-31

5. Long-term change in the target achievement rate of low-density lipoprotein cholesterol in patients with cardiovascular disease;Int. Journal of Clinical Pharmacology and Therapeutics;2023-04-01